HotSpot Therapeutics presents Phase 1 data on HST-1011
The CBL-B inhibitor was generally well tolerated with no dose-limiting toxicities, and tumor stasis or shrinkage occurred in 10 of 28 heavily pre-treated patients.
See the latest news and media coverage for HotSpot. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing allosteric medicines for autoimmune diseases
hotspotthera.comLast updated
The CBL-B inhibitor was generally well tolerated with no dose-limiting toxicities, and tumor stasis or shrinkage occurred in 10 of 28 heavily pre-treated patients.
The Phase 1/2 study tests the oral CBL-B inhibitor in advanced solid tumors, alone and with Regeneron's Libtayo (cemiplimab).
HotSpot receives $40 million upfront and is eligible for up to $295 million in option fees and R&D milestones, plus royalties. AbbVie gains an exclusive worldwide option to license the autoimmune disease program.
Led by Pivotal bioVenture Partners, the round brings total funding to $190 million and will advance its Smart Allostery platform and pipeline toward the clinic.
BOSTON, Jan. 3, 2023 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies for the...
AbbVie (NYSE: ABBV) and HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer...
HotSpot Therapeutics, Inc. is a biotechnology company that is pioneering a new class of allosteric drugs that target certain naturally occurring pockets on proteins called...
BOSTON, Jan. 10, 2022 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first- and best-in-class allosteric therapies targeting regulatory...
Track HotSpot and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to HotSpot and other trending companies.